期刊文献+

RNA干扰技术抑制人肺鳞癌细胞株的VEGF-C基因表达

Inhibition effect of siRNA on VEGF-C in patients with lung square cancer
原文传递
导出
摘要 目的研究RNA干扰技术沉默血管内皮生长因子-C(vascular endothelial growth factor-C,VEGF-C)在人肺鳞癌SK-MES-1细胞中的表达情况,为肺癌的RNAi基因治疗提供实验依据。方法设计三组siRNAs(siRNA1、siRNA2、siRNA3),确认VEGF-C-siRNA,构建pGenesil.1-VEGF-C的干涉载体,稳定转染入肺鳞癌细胞株SK-MES-1,通过RT-PCR和Western-blot技术检测VEGF-C在细胞中的表达。结果 siR-NA1、siRNA2、siRNA3组均抑制SK-MES-1细胞增殖,其中siRNA1转染对SK-MES-1细胞VEGF-C增殖有明显抑制作用,其抑制率为72.45%,明显高于空白对照组、空脂质体组、阴性对照siRNA组(P<0.01);siR-NA-VEGF-C组细胞内VEGF-C蛋白表达明显低于空白对照组、空脂质体组,对VEGF-C蛋白表达下调率分别为54%、65%、6%,差异具有显著统计学意义(P<0.05)。结论 RNA干扰技术能够明显抑制SK-MES-1细胞中VEGF-C的表达,从而抑制肺癌发生淋巴转移。 Objective To investigate the inhibitation effect of VEGF-C expression in SK-MES-1 cells by RNA interfering.Methods Three small interfering RNAs(siRNAa,siRNAb,siRNAc)were prepared and designed VEGF-C-siRNA.The constructed pGenesil.1-VEGF-C vectors were stably transfected into SK-MES-1 cell line.Then the expression of VEGF-C was detected in stable transfection SK-MES-1 cell line by RT-PCR and Western-blot.Results RT-PCR results showed that siRNA1,siRNA2,siRNA3 could inhibit the growth of SK-MES-1 cells,among which siRNA1 was the most significant,with an inhibition rate of 72.45%,significantly higher than blank control group,empty plasmid group or siRNA negative group(P0.01).The VEGF-C protein expression of siRNA-VEGF-C cells significantly lower than blank control group,empty plasmid group,down-regulated expression of VEGF-C protein was 54%,65%,6% respectively,there was significant statistical significance(P0.05).Conclusion RNAi technology could silence the expression of VEGF-C in SK-MES-1 cells,Which suggested that the technology may be one of the effective methods for inhibiting lymphmetastasis in lung squre cancer.
出处 《中华肺部疾病杂志(电子版)》 CAS 2011年第1期22-25,共4页 Chinese Journal of Lung Diseases(Electronic Edition)
关键词 RNAI 血管内皮生长因子-C SK—MES-1细胞 RNAi Vascular endothelial growth factor-C SK-MES-1 cells
  • 相关文献

参考文献9

  • 1张敏,张新,白春学,陈杰,MinQ. Wei.RNA干扰技术抑制非小细胞肺癌表皮生长因子受体的表达[J].中华内科杂志,2004,43(5):345-348. 被引量:10
  • 2LI Qiu li, CHEN Fu jingDepartment of Head &Neck,Cancer Center,Sun Yat sen University,Guangzhou 510060,P.R.China.血管内皮生长因子-C、-D与肿瘤淋巴道转移研究进展[J].癌症,2002,21(6):696-700. 被引量:22
  • 3Otrock ZK,Makarem JA,Shamseddine AI.Vascular endothelial growth factor family of ligands and receptors: review. Blood Cells Molecules Diseases . 2007 被引量:1
  • 4AV Benest,SJ Harper,SY Herttuala,K Alitalo,DO Bates.VEGF-C induced angiogenesis preferentially occurs at a distance from lymphangiogenesis. Cardiovascular Research . 2008 被引量:1
  • 5Paavonen K,Horelli-Kuitunen N,Chilov D,et al.Novel human vascular endothelial growth factor genes VEGF-B and VEGF-C localized to chromosomes 11q13 and 4q34, respectively. Circulation . 1996 被引量:1
  • 6He Y,Rajantie I,Pajusola K,et al.Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels. Cancer Research . 2005 被引量:1
  • 7Pytowski B,Goldman J,Persaud K,et al.Complete and specific inhibition of adult lymphatic regeneration by a novel VEGFR-3 neutralizing antibody. Journal of the National Cancer Institute . 2005 被引量:1
  • 8Lin J,Lalani AS,Harding TC,et al.Inhibition of lymphogenous metastasis using adeno-associated virusmediated gene transfer of a soluble VEGFR-3 decoy receptor. Cancer Research . 2005 被引量:1
  • 9Roberts N,Kloos B,Cassella M,et al.Inhibition of VEGFR-3 activation with the antagonistic antibody more potently suppresses lymph node and distant metastases than inactivation of VEGFR-2. Cancer Research . 2006 被引量:1

二级参考文献36

  • 1Wakeling AE.Epidermal growth factor receptor tyrosine kinase inhibitors.Curr Opin Pharmacol,2002,2:382-387. 被引量:1
  • 2Elbashir SM,Lendeckel W,Tuschl T.RNA interference is mediated by 21-and 22-nucleotide RNAs.Genes Dev,2001,15:188-200. 被引量:1
  • 3Nagy P,Arndt-Jovin DJ,Jovin TM.Small interfering RNAs suppress the expression of endogenous and GFP-fused epidermal growth factor receptor (erbB1) and induce apoptosis in erbB1-overexpressing cells.Exp Cell Res,2003,285:39-49. 被引量:1
  • 4Magne N,Fischel JL,Dubreuil A,et al.Sequence-dependent effects of ZD1839 ('Iressa') in combination with cytotoxic treatment in human head and neck cancer.Br J Cancer,2002,86:819-827. 被引量:1
  • 5Huang SM,Li J,Armstrong EA,et al.Modulation of radiation response and tumor-induced angiogenesis after epidermal growth factor receptor inhibition by ZD1839 (Iressa).Cancer Res,2002,62:4300-4306. 被引量:1
  • 6Hirata A,Ogawa S,Kometani T,et al.ZD1839 (Iressa) induces antiangiogenic effects through inhibition of epidermal growth factor receptor tyrosine kinase.Cancer Res,2002,62:2554-2560. 被引量:1
  • 7Tsai CM,Chang KT,Li L,et al.Interrelationships between cellular nucleotide excision repair,cisplatin cytotoxicity,HER-2/neu gene expression,and epidermal growth factor receptor level in non-small cell lung cancer cells.Jpn J Cancer Res,2000,91:213-222. 被引量:1
  • 8Yonemura Y;Endo Y;FuJita H.Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer,1999. 被引量:2
  • 9Cao Y;Linden P;Farnebo J.Vascular endothelial growth factor C induces angiogenesis in vivo[J],1998(24). 被引量:1
  • 10Joukov V;Pajusola K;Kaipainen A.A novel vascular endothelial growth factor,VEGF C,is a ligand for the Flt 4(VEGFR 3) and KDR (VEGFR 2) receptor tyrosine kinases,1996(02). 被引量:1

共引文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部